According to Biologics Market Analysis 2019 to 2023 Global Industry research report published by Market Research Future, the Global Biologics Market Size to reach USD 285,520.4 million value at 6.95% CAGR by Forecast Period of 2019 to 2023. Market for Biologics Industry is Segmented by Product (Monoclonal Antibody, Interleukins, Vaccines, Growth Factors, Gene Therapy, Others), by Disease Indication (Rheumatoid Arthritis, Psoriasis/Psoriatic Arthritis, Cancer, Diabetes, Others), by Manufacturing (In-house, Sourced), and Region – Global Opportunity Analysis with Industry Forecast, 2018 – 2023.
Biologics Market Companies Studied in report include AbbVie, Inc. (U.S.), Pfizer Inc. (U.S.), AstraZeneca (U.K.), Novartis AG (Switzerland), F. Hoffman-La Roche AG (Switzerland), Bayer AG (Germany), Amgen (U.S.), Sanofi (France), Eli Lilly and Company (U.S.), GlaxoSmithKline Plc (U.K.), and others.
Get Sample Biologics Industry Research Report – Global Forecast to 2023 at: https://www.marketresearchfuture.com/sample_request/1339
Global Biologics Market Insights:
Biologics are products derived from human, animals, and microorganisms through biotechnology. Drugs produced using biologics are being used to treat an array of chronic diseases. Continuous innovation in the pharmaceutical sector is likely to boost the demand for biologics. The Global Biologics Market is anticipated to experience growth at 6.95% CAGR from 2018 to 2023 (forecast period), states Market Research Future (MRFR) in its latest report. It is predicted to reach a valuation of USD 285,520.4 million by the end of the forecast period.
Presence of various chronic diseases is one of the primary drivers of the market. Rising awareness regarding the performance and efficacy of biologics is projected to boost market volume exponentially till 2023.The inflated healthcare expenditure of nations to combat acute diseases and improve the mortality rate is likely to trigger the demand for biologics. South Africa and UAE are prime instances of countries which have increased their healthcare budget to promote quality care in hospitals. Rapid urbanization and improvements in healthcare infrastructure are likely to influence market demand in the coming years.
Investments in R&D by pharmaceutical manufacturing companies to enhance the performance of biologics are likely to act as a catalyst in the market. Advances in biologics owing to emergence of personalized medicines and orphan drugs can bolster the biologics market volume considerably till 2023. But emergence of biosimilars owing to the patent expiration of various drugs can threaten the market growth.
Key Questions answered in report:
What is the market size of Biologics industry in Asia Pacific, North America, Europe, And Middle East?
Who are the leading players in the Biologics Industry?
Which key players are dominating the Global Biologics market?
What will be the forecast of the Biologics market for the next 5 years?
What is the market demand of the Biologics Industry?
What will be the upcoming trends in the Biologics Market?
What is the market size and growth rate of the Global Biologics market?
What are some factors that affect the Biologics market?
What will be the future of Biologics market in coming years?
Biologics Global Market Segment Analysis:
By product, the Biologics Market is segmented into monoclonal antibody, interleukins, vaccines, growth factors, gene therapy, and others. Monoclonal antibody is further segmented into humanized, human, chimeric, and murine.
By disease indication, it is segmented into cancer, diabetes, rheumatoid arthritis, psoriasis/psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, Crohn’s disease, juvenile idiopathic arthropathy, cardiovascular diseases, and others.
By manufacturing, two major methods are discussed, mainly outsourced and in-house.
Biologics Global Market Regional Analysis:
The APAC region is anticipated to experience the highest CAGR of 5.53% over the forecast period. This can be attributed to the presence of various contract manufacturing organizations (CMOs). The increasing geriatric populace and the changing healthcare sector are other factors predicted to augment market size till 2023. The Indian market can heavily contribute to regional market revenue owing to its huge strides in manufacturing biologics.
The Americas accounted for a large share of the biologics market in 2017 owing to rapid adoption of manufacturing technologies and strong economic growth of U.S. and Canada. Investments in new facilities to produce drugs for clinical trials is likely to boost regional market growth till 2023. For instance, CRB USA built a state-of-the-art unit for stage I-III clinical trials in 2017. The region can expand at 4.31% CAGR over the forecast period to reach USD 129,652.7 million by 2023.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Continued…
List of Tables:
TABLE 1 GLOBAL BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION) 34
TABLE 2 GLOBAL BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY REGION, 2015 TO 2023 (USD MILLION) 35
TABLE 3 GLOBAL BIOLOGICS MARKET FOR INTERLEUKINS BY REGION, 2015 TO 2023 (USD MILLION) 36
TABLE 4 GLOBAL BIOLOGICS MARKET FOR HUMAN BY REGION, 2015 TO 2023 (USD MILLION) 36
TABLE 5 GLOBAL BIOLOGICS MARKET FOR CHIMERIC BY REGION, 2015 TO 2023 (USD MILLION) 36
TABLE 6 GLOBAL BIOLOGICS MARKET FOR MURINE BY REGION, 2015 TO 2023 (USD MILLION) 37
TABLE 7 GLOBAL BIOLOGICS MARKET FOR INTERLEUKINS BY REGION, 2015 TO 2023 (USD MILLION) 37
TABLE 8 GLOBAL BIOLOGICS MARKET FOR VACCINES BY REGION, 2015 TO 2023 (USD MILLION) 38
TABLE 9 GLOBAL BIOLOGICS MARKET FOR GROWTH FACTORS BY REGION, 2015 TO 2023 (USD MILLION) 39
TABLE 10 GLOBAL BIOLOGICS MARKET FOR GENE THERAPY BY REGION, 2015 TO 2023 (USD MILLION) 39
TABLE 11 GLOBAL BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION) 41
TABLE 12 GLOBAL BIOLOGICS MARKET FOR CANCER BY REGION, 2015 TO 2023 (USD MILLION) 42
Continued…
Browse Complete Report at: https://www.marketresearchfuture.com/reports/biologics-market-1339
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/biologics-market-1339